Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38302841)

  • 1. Alterations in the gut microbiota and their metabolites in human intestinal epithelial cells of patients with colorectal cancer.
    Jahani-Sherafat S; Azimirad M; Raeisi H; Azizmohammad Looha M; Tavakkoli S; Ahmadi Amoli H; Moghim S; Rostami-Nejad M; Yadegar A; Zali MR
    Mol Biol Rep; 2024 Feb; 51(1):265. PubMed ID: 38302841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer.
    Zhang H; Jin K; Xiong K; Jing W; Pang Z; Feng M; Cheng X
    Cancer Med; 2023 Jul; 12(14):15720-15735. PubMed ID: 37260140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
    Zhang Q; Zhao H; Wu D; Cao D; Ma W
    BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens.
    Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
    mSphere; 2023 Apr; 8(2):e0062622. PubMed ID: 36847529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota-derived metabolites in CRC progression and causation.
    Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
    Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
    Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits.
    Shiroma H; Shiba S; Erawijantari PP; Takamaru H; Yamada M; Sakamoto T; Kanemitsu Y; Mizutani S; Soga T; Saito Y; Shibata T; Fukuda S; Yachida S; Yamada T
    mSystems; 2022 Apr; 7(2):e0001822. PubMed ID: 35311577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.
    Zhang Y; Yu X; Yu E; Wang N; Cai Q; Shuai Q; Yan F; Jiang L; Wang H; Liu J; Chen Y; Li Z; Jiang Q
    BMC Microbiol; 2018 Aug; 18(1):92. PubMed ID: 30157754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metagenomic and targeted metabolomic analyses reveal distinct phenotypes of the gut microbiota in patients with colorectal cancer and type 2 diabetes mellitus.
    Yang Y; Han Z; Gao Z; Chen J; Song C; Xu J; Wang H; Huang A; Shi J; Gu J
    Chin Med J (Engl); 2023 Dec; 136(23):2847-2856. PubMed ID: 36959686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
    Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
    Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis.
    Du X; Li Q; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Chen G; Yue H; Li J; Zhao M; Han YP; Fu X
    Front Physiol; 2022; 13():854545. PubMed ID: 35600308
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer.
    Xi Y; Yuefen P; Wei W; Quan Q; Jing Z; Jiamin X; Shuwen H
    J Transl Med; 2019 Oct; 17(1):353. PubMed ID: 31665031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
    Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
    Langdon A; Schwartz DJ; Bulow C; Sun X; Hink T; Reske KA; Jones C; Burnham CD; Dubberke ER; Dantas G;
    Genome Med; 2021 Feb; 13(1):28. PubMed ID: 33593430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosa-associated microbiota signature in colorectal cancer.
    Gao R; Kong C; Huang L; Li H; Qu X; Liu Z; Lan P; Wang J; Qin H
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2073-2083. PubMed ID: 28600626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
    Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
    Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway.
    Wei J; Zheng Z; Hou X; Jia F; Yuan Y; Yuan F; He F; Hu L; Zhao L
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116866. PubMed ID: 37429503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
    Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
    Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.